$SABS
SAB Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
$2.95
▲+2.08%+$0.060
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSAB Biotherapeutics, Inc. Common Stock
XNAS•Health Care•Biological Products, (No Diagnostic Substances)
Why is SABS up today? It is at $2.95 (+2.08%), and our scanner flagged it 42 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SABS spikes, and full due diligence on SABS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SABS 42 times in the last 30 days. Create a free account to track $SABS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
SABS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on SABS today, peaking at 8.0x its normal volume.
Likely catalystSAB Biotherapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 18, 2026 · 20 days agoAcross every filing on file, supply equal to 1928.2% of the tradeable float is in play - 1928.2% has already been sold.
One filing exceeds the whole float, which usually means our share count is stale. Check the filing directly.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
400,000,000 new shares
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Kropotova Alexandra Officer | Sold (automatic/other) | -473 | sold 1.1% | 42K | n/a | Sep 17, 26 |
Kropotova Alexandra Officer | Sold (automatic/other) | -988 | sold 2.3% | 42K | n/a | Jun 25, 26 |
Kropotova Alexandra Officer | Sold (automatic/other) | -988 | sold 2.2% | 43K | n/a | Mar 24, 26 |
Kropotova Alexandra Officer | Sold (automatic/other) | -988 | sold 2.2% | 44K | n/a | Dec 11, 25 |
Sessa Capital (Master), L.P. Director | Other | 1.74M 1.9% of company | added 100% | 2.20M | $3.0M at $1.75 | Sep 29, 25 |
Moin Andrew Director | Other | 1.74M 1.9% of company | added 100% | 2.20M | $3.0M at $1.75 | Sep 29, 25 |
Kropotova Alexandra Officer | Sold (automatic/other) | -2K | sold 4.2% | 45K | n/a | Sep 19, 25 |
Kropotova Alexandra Officer | Sold (automatic/other) | -1K | sold 2.4% | 47K | n/a | Mar 27, 25 |
Kropotova Alexandra Officer | Sold (automatic/other) | -9K | sold 16% | 48K | n/a | Dec 18, 24 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
SABS is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on SABS today, peaking at 8.0x its normal volume.
SABS last traded at $2.95, up 2.08% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
SAB Biotherapeutics, Inc. Common Stock (SABS) is next expected to report earnings on Friday, November 13, 2026, about 35 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SABS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SABS 42 times in the last 30 days.
SABS (SAB Biotherapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $263M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SABS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SABS discussion
Sign in to ask a question or join the discussion.